Hema-NeoTIL01 Cell Infusion Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hema-NeoTIL01 Cell Infusion Therapy, covering 2024-08-19 to 2024-08-19. Get the full timeline:
Most recent: Clinical Trial Update: Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia [EARLY_Phase 1]